Aclaris Therapeutics logo
Aclaris Therapeutics
ACRS | NASDAQ
Chart Builder DCF Calculator
$3.60
-$0.32 (-8.16%)
At close: Nov 16, 2026, 4:00 PM ET
$3.66
+$0.06 (+1.66%)
After-hours: Nov 16, 2026, 7:30 PM ET

Aclaris Therapeutics Institutional Ownership

Institutional ownership explained

Institutional Ownership

Net Inflow
Dollar & Volume Weighted
Total Institutions
156
Total Ownership
83.71%
Capital Flow
+$222.47M
Shares Change
+10.28M
Ownership Distribution
Institutions (83.71%)
Others (16.29%)

Institutional Sentiment

Overall: bullish
Equity Sentiment & Activity
bullish
New Positions
30
Increased Positions
93
Reduced Positions
34
Closed Positions
15
New (30)
Increased (93)
Reduced (34)
Closed (15)
Options Sentiment & Activity
bullish
Put/Call Ratio
0.261
Call Flow
602,700
Put Flow
157,100
Calls (79%)
Puts (21%)

Super Investors

Super Investor / Fund Ownership Portfolio Weight Shares Market Value
Renaissance Technologies LLC
0.57%
+62.65%
< 0.01%
817.53K
3.26M

Top Shareholders

Institution Ownership Portfolio Weight Shares Market Value
Ra Capital Management, L.p.
8.91%
+68.75%
0.58%
+116.34%
12.72M
+86.99%
67.3M
+163.78%
Bml Capital Management, LLC
8.39%
-24.16%
35.98%
+4.88%
11.98M
-15.96%
63.35M
+18.55%
Blackrock, Inc.
7.03%
+22.28%
< 0.01%
+62.58%
10.04M
+35.51%
53.1M
+91.15%
Pro Membership

Stop Guessing, Start Knowing.

Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.

Unlimited access

Unlimited access to all data and tools, giving you the edge over everyone else in the market.

Proprietary Stock Rating Score

Evaluate stocks with our proprietary rating score based on fundamentals, economic moat, and sentiment.

Top Wall Street Analyst Ratings

Follow ratings from the best analysts on Wall Street to stay ahead of market moves.

Up to 30 years financial history

We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.